Happy 2026, Brand Builders — welcome back to The Brand Blueprint! 🎉
In this Scaling Capsule episode, I’m joined by Fitz Light, Founder & CEO of FlightSuite—an AI-powered CRM platform built to help service-based businesses automate outreach, follow-up, and operations. Fitz is a recognized 2025 Charlotte 30 Under 30, started college at 18, earned a Master’s in Finance from Vanderbilt by 21, and transitioned from investment banking into building a practical AI platform that turns your CRM into an “employee” that never sleeps.

If you’re a founder building a service business—or a SaaS founder selling to them—this episode is packed with actionable strategy: how to sell before you build, how to niche down, how to price subscription products, and what metrics matter most when scaling.

What you’ll learn

• The “sell before you build” playbook (and how Fitz pre-sold before building)

• Why data + KPIs turn a “job” into a scalable business

• How FlightSuite turns a CRM into an AI assistant (capture leads, answer FAQs, route tasks)

• Niching down: why Fitz targeted CPAs to solve tax season demand spikes

• Pricing strategy: why simple subscription pricing wins

• KPIs that matter: retention, LTV, AOV

• Hiring: when to use offshore contractors and how to train for SOP success

• Capital fit: debt vs equity vs revenue-based (and when each makes sense)

Chapters
00:00 Welcome + Scaling Capsule intro
00:45 Who is Fitz Light + FlightSuite overview
02:00 Rapid Fire: routines, reading, authenticity & “The Courage to be Disliked”
07:30 Fitz’s TEDx and why authenticity reduces anxiety
12:05 Origin story: job loss → AI obsession → founder path
13:40 “Random coffee shop” moment that sparked the business model
15:00 The core insight: if you don’t know the data, it’s a job—not a business
17:10 What FlightSuite does: CRM as employee + no-code automations
20:30 Niching down: CPAs as the 2026 growth wedge
23:15 Go-to-market: paid marketing, keywords, outbound, receptionist champion strategy
28:10 Ideal customer profile: mid-sized firms with messy tech stacks
30:15 Pricing: subscription model vs one-time buildouts vs usage
35:40 KPIs: retention, LTV, AOV
38:20 Hiring: offshore contractors, training, SOPs, accountability
42:40 Capital fit: debt vs equity vs revenue-based financing
47:40 Closing: where to find FlightSuite + connect with Fitz
• Subscribe: YouTube | Apple | Spotify

✅ If this episode helped, please like, subscribe, and share with a founder building in SaaS or service businesses.
#TheBrandBlueprint #FlightSuiteAI #Scaling #AI #CRM #SaaS #Automation #GoToMarket #Startup #Founder #SmallBusiness #CustomerRetention #Vanderbilt #Charlotte

Happy New Year 2026! 🎉 We’re back with our SeedSpot Special featuring founders who are scaling impact-driven brands from idea to shelf. Today we sit down with Victorine Sarr, Founder & CEO of Lyvv Cosmetics (operating in the U.S. as Maison Lyvv): a Dakar-born clean color brand built for global consumers.

What you’ll learn

• Why Product (quality + performance) beats everything long-term

• How Amazon becomes a data engine for first U.S. doors

• Regulatory nuance: “natural” vs “organic,” INCI, and compliant copy

• Packaging & brand naming for U.S. (Maison LYVV), UPCs, retail-ready details

• African distribution realities: ECOWAS, currency, tariffs, and world-class partners

• The four Ps (Product, Price, Place, Promo)—and why Product is Victorine’s #1

Chapters

00:00 Happy New Year 2026 + SeedSpot Special intro

00:45 Meet Victorine Sarr & LYVV / Maison LYVV

01:35 Corporate springboard: L’Oréal & Apple

02:40 Rapid Fire: breakfasts, spices, favorite U.S. food, 2026 word = “groundbreaking”

04:55 54 countries ≠ one market: ECOWAS, currencies, culture (Africa basics)

06:25 Why lip SKUs first; shades/textures; data-guided picks

08:05 Validating demand; airport spa activation; SA → SN → Côte d’Ivoire

11:15 The messy reality of African distribution (partners, paperwork, currency)

12:20 U.S. entry: Amazon → indie & specialty → national retail

13:20 Compliance & claims: INCI, “natural” vs “organic,” copy and language

14:20 Packaging & barcodes: glass, retail-ready details, UPCs

15:15 U.S. trademark pivot: operating as Maison LYVV

16:30 SeedSpot training: data-driven retail pitches & readiness checklist

18:00 Closing takeaways + how to support Maison LYVV

Help us kick off 2026 strong—like, subscribe, and share with a founder who’s scaling this year.

Hashtags: #BrandBlueprint #SeedSpot #CleanBeauty #AfricanBeauty #MaisonLYVV #LYVV #CPG #DTC #RetailStrategy #AmazonSeller #INCI #ECOWAS #GoToMarket

Hey Brand Builders,

If you’ve ever wondered how anyone actually scales a biotech company in one of the most regulated, complex industries on earth — without venture capital and big-pharma profit pressure — this episode is for you.

I’m sitting down with Eric Moyal, Founder and Executive Director of Project Insulin, a nonprofit on a mission to produce its own generic insulin and sell it directly to patients at cost. No price gouging, no games with insurance, and a clear focus on the 1.3 million Americans who are currently rationing their insulin.

We get into:

• How Eric’s journey as a professional nonprofit fundraiser and his sister’s rare illness pushed him into health equity work

• The moment he realized insulin hasn’t meaningfully changed in 30 years — but the price has

• What it really takes (time, money, and emotional stamina) to develop a biosimilar drug from scratch

• Why he chose a nonprofit model over a traditional startup

• How LinkedIn and intentional networking literally built the foundation for Project Insulin

• The mindset shift founders need when they’re building something that might take 5–10 years to fully materialize

If you’re building anything in biotech, health equity, regulated industries, or long-timeline ventures, this is a masterclass in patience, planning, and asking for help.

________________________________________

About Eric Moyal

Eric Moyal is the Founder and Executive Director of Project Insulin, a nonprofit working to produce a generic long-acting insulin and sell it directly to patients at cost, regardless of insurance status.

He’s a professional nonprofit fundraiser, board member for a CRPS organization, and a deeply mission-driven founder with a background in higher-ed fundraising, health equity, and relationship-based capital raising.

When he’s not grinding on drug development timelines, you can find him in spin class, eating Frosted Mini-Wheats, or demystifying LinkedIn for other founders.

________________________________________

Connect with Eric & Project Insulin

• Website: projectinsulin.org

• Email: emoyal@projectinsulin.org

• Learn how to volunteer, host a fundraiser, or support their next phase of drug development on the site.

________________________________________

Chapters / Timestamps

0:00 – Intro: Why insulin access and health equity matter

2:00 – Rapid Fire: Coffee vs tea, cereal, mornings, and spin class

5:15 – Founder tools: LinkedIn, Monday, and staying out of procrastination mode

7:00 – How Eric actually uses LinkedIn to build real relationships

11:00 – “Professional fundraiser”: what that really means in the nonprofit world

15:00 – Eric’s sister, rare illness, and learning the cost of healthcare the hard way

18:30 – The Boston-to-Miami bike ride for awareness and fundraising

22:30 – CRPS, TOS, and becoming a board member for a rare disease nonprofit

24:30 – Meeting his partner with Type 1 diabetes and discovering insulin hasn’t changed in 30 years

26:30 – The moment he realized insulin is a money problem, not a science problem

27:30 – What Project Insulin actually does and how the model works

30:30 – Cutting out the middlemen: pharma, PBMs, wholesalers, and insurance

35:00 – From U.S. launch to global impact: regulatory pathways and ambitions

36:30 – Who Project Insulin is really for: the 1.3M Americans rationing insulin

39:00 – Access, awareness, and partnerships with clinics, FQHCs, VA, and ADA

43:00 – Eric’s 3-month, 6-month, and 3-year roadmap for drug development and fundraising

47:00 – What he wishes he’d known earlier (and why he’d still start with networking)

51:00 – Burnout, LinkedIn comparison, and the lie that “everyone else is winning”

55:00 – “Nobody cares” (in the best way): why you should still celebrate your small wins

57:00 – Who Eric needs to meet next: health equity funders, operations leaders, and volunteers

1:00:00 – Dana’s closing + how to support Project Insulin and The Brand Blueprint

________________________________________